Medicine evaluation figures

The European Medicines Agency (EMA) publishes information on the volume and outcome of marketing authorisation and post-authorisation applications for human and veterinary medicines that it evaluates.

The documents on this page contain factual information on medicines evaluation, presented on an annual and monthly basis.

For commentaries and analysis, see the Agency's annual reports.

For the main outcomes of the monthly plenary meetings of the Agency's seven scientific committees, see Committee highlights.

Annual medicines highlights (updated)

Human medicines

In 2019, EMA adopted recommendations on:

Human medicines: highlights of 2019

Veterinary medicines

In 2019, EMA adopted recommendations on:

Veterinary medicines: highlights of 2019

PDF icon Human medicines highlights 2019

Previous highlights:

PDF iconHuman medicines highlights 2018

PDF iconHuman medicines highlights 2017 (interactive)

PDF iconHuman medicines highlights 2016

PDF iconHuman medicines highlights 2015

PDF iconVeterinary medicines highlights 2019

Previous highlights:

PDF iconVeterinary medicines highlights 2018

PDF iconVeterinary medicines highlights 2017

PDF iconVeterinary medicines highlights 2016

PDF iconVeterinary medicines highlights 2015

 

Monthly figures

For monthly evaluation figures on human medicines, see:

For monthly evaluation figures on veterinary medicines, see the monthly reports of the Committee for Medicinal Products for Veterinary Use (CVMP) on CVMP: Agendas and outcomes.

2019

2018

2017

2016

How useful was this page?

Add your rating